From the end of February, Belgium will start offering the Novavax coronavirus vaccine – called Nuvaxovid – to people who are allergic to the other available vaccines or had proven side effects after a first dose of Pfizer or Moderna. On Wednesday, the Interministerial Conference (IMC) on Public Health decided to purchase 510,000 doses of […]
Source: The Brussels Times